Follicum Bioglan

Swedish company Follicum has announced new information regarding their clinical trial schedule and product development. The last completed milestone we had heard from Follicum was results from their phase 2a clinical trial of FOL-005. During that trial which completed in late 2018, the peptide FOL-005 was injected into the scalps of 60 participants three times…